AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia
Authors: Rots, MG Pieters, R Jansen, G Kaspers, GJL Van Zantwijk, CH Noordhuis, P Voorn, DA Van Wering, ER Creutzig, U Veerman, AJP Peters, GJ
Citation: Mg. Rots et al., A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia, EUR J CANC, 37(4), 2001, pp. 492-498
Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay
Authors: Schouten-van Meeteren, AYN van der Valk, P van der Linden, HC Moll, AC Imhof, SM Huismans, DR Loonen, AH Veerman, AJP
Citation: Ayn. Schouten-van Meeteren et al., Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay, CANCER, 92(11), 2001, pp. 2933-2940
TEL/AML1 fusion is not a prognostic factor in Dutch childhood acute lymphoblastic leukaemia
Authors: Hubeek, I Ramakers-van Woerden, NL Pieters, R Slater, R Beverloo, HB van Wering, ER Kamps, W Hahlen, K Veerman, AJP
Citation: I. Hubeek et al., TEL/AML1 fusion is not a prognostic factor in Dutch childhood acute lymphoblastic leukaemia, BR J HAEM, 113(1), 2001, pp. 254-255
In vitro drug resistance and prognostic impact of p16(INK4A)/p15(INK4B) deletions in childhood T-cell acute lymphoblastic leukaemia
Authors: Ramakers-van Woerden, NL Pieters, R Slater, RM Loonen, AH Beverloo, HB van Drunen, E Heyman, M Moreno, TC Rots, MG van Wering, ER Kamps, WA Janka-Schaub, GE Veerman, AJP
Citation: Nl. Ramakers-van Woerden et al., In vitro drug resistance and prognostic impact of p16(INK4A)/p15(INK4B) deletions in childhood T-cell acute lymphoblastic leukaemia, BR J HAEM, 112(3), 2001, pp. 680-690
Inflammatory mediators in dengue virus infection in children: Interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2
Authors: Juffrie, M Van der Meer, GM Hack, CE Sutaryo, KH Veerman, AJP Thijs, LG
Citation: M. Juffrie et al., Inflammatory mediators in dengue virus infection in children: Interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2, AM J TROP M, 65(1), 2001, pp. 70-75
Modulation of glucocorticoid resistance in childhood acute lymphoblastic leukemia; Preliminary results
Authors: Haarman, EG Kaspers, GJL Pieters, R Rottier, MMA Veerman, AJP
Citation: Eg. Haarman et al., Modulation of glucocorticoid resistance in childhood acute lymphoblastic leukemia; Preliminary results, HEMAT BLOOD, 40, 2001, pp. 236-243
In-vitro cellular drug resistance in acute non-lymhoblastic leukemia: Comparisons between adults and children
Authors: de Haas, TGKJ Zwaan, CM Wondergem, MJ Pieters, R Kaspers, GJL Loonen, AH Rottier, MMA Wunsche, R Creutzig, U Bartl, S Hahlen, K Broxterman, HJ Ossenkoppele, GJ Veerman, AJP
Citation: Tgkj. De Haas et al., In-vitro cellular drug resistance in acute non-lymhoblastic leukemia: Comparisons between adults and children, HEMAT BLOOD, 40, 2001, pp. 244-250
mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method
Authors: Rots, MG Willey, JC Jansen, G Van Zantwijk, CH Noordhuis, P DeMuth, JP Kuiper, E Veerman, AJP Pieters, R Peters, GJ
Citation: Mg. Rots et al., mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method, LEUKEMIA, 14(12), 2000, pp. 2166-2175
Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991
Authors: Kamps, WA Veerman, AJP van Wering, ER van Weerden, JF Slater, R van der Does-van den Berg, A
Citation: Wa. Kamps et al., Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991, LEUKEMIA, 14(12), 2000, pp. 2240-2246
Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: No long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group
Authors: Rammeloo, LAJ Postma, A Sobotka-Plojhar, MA Bink-Boelkens, MTE van der Does-van der Berg, A Veerman, AJP Kamps, WA
Citation: Laj. Rammeloo et al., Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: No long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group, MED PED ONC, 35(1), 2000, pp. 13-19
Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: A multicenter study in The Netherlands
Authors: van Rossum, AMC Niesters, HGM Geelen, SPM Scherpbier, HJ Hartwig, NG Weemaes, CMR Veerman, AJP Suur, MH de Graeff-Meeder, ER Slicker, WAT Hop, WCJ Osterhaus, ADME Burger, DM de Groot, R
Citation: Amc. Van Rossum et al., Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: A multicenter study in The Netherlands, J PEDIAT, 136(6), 2000, pp. 780-788
Inflammatory mediators in dengue virus infection in children: Interleukin-8 and its relationship to neutrophil degranulation
Authors: Juffrie, M van der Meer, GM Hack, CE Haasnoot, K",Sutaryo,"Veerman, AJP Thijs, LG
Citation: M. Juffrie et al., Inflammatory mediators in dengue virus infection in children: Interleukin-8 and its relationship to neutrophil degranulation, INFEC IMMUN, 68(2), 2000, pp. 702-707
Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia
Authors: Rots, MG Pieters, R Kaspers, GJL Veerman, AJP Peters, GJ Jansen, G
Citation: Mg. Rots et al., Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia, BR J HAEM, 110(4), 2000, pp. 791-800
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia
Authors: Styczynski, J Pieters, R Huismans, DR Schuurhuis, GJ Wysocki, M Veerman, AJP
Citation: J. Styczynski et al., In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia, BR J HAEM, 110(4), 2000, pp. 813-818
Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia
Authors: Rots, MG Pieters, R Peters, GJ Noordhuis, P Van Zantwijk, CH Henze, G Janka-Schaub, GE Veerman, AJP Jansen, G
Citation: Mg. Rots et al., Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia, BR J HAEM, 109(3), 2000, pp. 629-634
Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia
Authors: Zwaan, CM Kaspers, GJL Pieters, R Ramakers-Van Woerden, NL den Boer, ML Wunsche, R Rottier, MMA Hahlen, K van Wering, ER Janka-Schaub, GE Creutzig, U Veerman, AJP
Citation: Cm. Zwaan et al., Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2779-2786
Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia
Authors: Zwaan, CM Kaspers, GJL Pieters, R Woerden, NLR den Boer, ML Wunsche, R Rottier, MMA Hahlen, K van Wering, ER Janka-Schaub, GE Creutzig, U Veerman, AJP
Citation: Cm. Zwaan et al., Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2879-2886
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia
Authors: Ramakers-van Woerden, NL Pieters, R Loonen, AH Hubeek, I van Drunen, E Beverloo, HB Slater, RM Harbott, J Seyfarth, J van Wering, ER Hahlen, K Schmiegelow, K Janka-Schaub, GE Veerman, AJP
Citation: Nl. Ramakers-van Woerden et al., TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia, BLOOD, 96(3), 2000, pp. 1094-1099
Effects of interleukin 3, interleukin 7, and B-cell growth factor on proliferation and drug resistance in vitro in childhood acute lymphoblastic leukemia
Authors: Duyn, AEJ Kaspers, GJL Pieters, R Van Zantwijk, CH Broekema, GJ Hahlen, K Veerman, AJP
Citation: Aej. Duyn et al., Effects of interleukin 3, interleukin 7, and B-cell growth factor on proliferation and drug resistance in vitro in childhood acute lymphoblastic leukemia, ANN HEMATOL, 78(4), 1999, pp. 163-171
Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia
Authors: Den Boer, ML Pieters, R Kazemier, KM Janka-Schaub, GE Henze, G Veerman, AJP
Citation: Ml. Den Boer et al., Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia, LEUKEMIA, 13(12), 1999, pp. 2023-2030
In vitro drug resistance as independent prognostic factor in study COALL-05-92 for treatment of childhood acute lymphoblastic leukemia: Basis for treatment stratification according to traditional risk factors and drug sensitivity in study COALL-06-97
Authors: Janka-Schaub, GE Harms, DO den Boer, ML Veerman, AJP Pieters, R
Citation: Ge. Janka-schaub et al., In vitro drug resistance as independent prognostic factor in study COALL-05-92 for treatment of childhood acute lymphoblastic leukemia: Basis for treatment stratification according to traditional risk factors and drug sensitivity in study COALL-06-97, KLIN PADIAT, 211(4), 1999, pp. 233-238
Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative study
Authors: Kaspers, CJL Zwaan, CM Veerman, AJP Rots, MG Pieters, R Bucsky, P Domula, M Gobel, U Graf, N Havers, W Jorch, N Kabisch, K Spaar, HJ Ritter, J Creutzig, U
Citation: Cjl. Kaspers et al., Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative study, KLIN PADIAT, 211(4), 1999, pp. 239-244
Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance
Authors: Den Boer, ML Kapaun, P Pieters, R Kazemier, KM Janka-Schaub, GE Veerman, AJP
Citation: Ml. Den Boer et al., Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance, BR J HAEM, 105(4), 1999, pp. 876-882
Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia
Authors: Den Boer, ML Pieters, R Kazemier, KM Janka-Schaub, GE Henze, G Creutzig, U Kaspers, GJL Kearns, PR Hall, AG Pearson, ADJ Veerman, AJP
Citation: Ml. Den Boer et al., Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia, BR J HAEM, 104(2), 1999, pp. 321-327
Circumvention of methotrexate resistance in childhood leukemia subtypes byrationally designed antifolates
Authors: Rots, MG Pieters, R Peters, GJ van Zantwijk, CH Mauritz, R Noordhuis, P Willey, JC Hahlen, K Creutzig, U Janka-Schaub, G Kaspers, GJL Veerman, AJP Jansen, G
Citation: Mg. Rots et al., Circumvention of methotrexate resistance in childhood leukemia subtypes byrationally designed antifolates, BLOOD, 94(9), 1999, pp. 3121-3128
Risultati: 1-25 | 26-27